Reticulated livedoid skin patterns after soft-tissue filler–related vascular adverse events - 19/06/24
, Peter J. Velthuis, MD, PhD a, Ali Mojallal, MD, PhD b, Guillaume Henry, MD b, Stefan O.P. Hofer, MD, PhD c, Sebastian C. Cotofana, MD, PhD a, d, eAbstract |
Background |
For the treatment of vascular adverse events caused by filler injections, duplex ultrasound imaging may be used. The findings of duplex ultrasound examination and the clinical features of reticulated livedoid skin patterns were compared with the hemifaces anatomy.
Objective |
The objective of this study was to link the reticulated livedoid skin patterns to the corresponding duplex ultrasound findings and the facial perforasomes.
Methods |
Duplex ultrasound imaging was used for the diagnosis and treatment of vascular adverse events. The clinical features and duplex ultrasound findings of 125 patients were investigated. Six cadaver hemifaces were examined to compare the typical livedo skin patterns with the vasculature of the face.
Results |
Clinically, the affected skin showed a similar reticulated pattern in each facial area corresponding with arterial anatomy and their perforators in the cadaver hemifaces. With duplex ultrasound, a disturbed microvascularization in the superficial fatty layer was visualized. After hyaluronidase injection, clinical improvement of the skin pattern was seen. Normalization of blood flow was noted accompanied by restoration of flow in the corresponding perforator artery. The skin patterns could be linked to the perforators of the superficial fat compartments.
Conclusion |
The livedo skin patterns seen in vascular adverse events may reflect the involvement of the perforators.
Le texte complet de cet article est disponible en PDF.Key words : facial anatomy, filler, injections, reticulated livedoid, vascular adverse events
Plan
| Funding sources: None. |
|
| IRB approval status: This study did not require ethics committee approval as ultrasound imaging is considered standard of care before and during vascular adverse events by the respective approval board according to The Medical Research Involving Human Subjects Act 10. |
Vol 91 - N° 1
P. 37-42 - juillet 2024 Retour au numéro
Article précédent
- Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database
- Rachita Pandya, Julianne Kleitsch, Darosa Lim, Victoria P. Werth
- JAAD Game Changer: Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: A prospective open study and review of the literature
- Faramarz Samie
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?